A2E, a Pigment of the Lipofuscin of Retinal Pigment Epithelial Cells, Is an Endogenous Ligand for Retinoic Acid Receptor
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Lipofuscin contains fluorophores, which represent a biomarker for cellular aging. Although it remains unsubstantiated clinically, experimental results support that the accumulation of lipofuscin is related to an increased risk of choroidal neovascularization due to age-related macular degeneration, a leading cause of legal blindness. Here, we report that a major lipofuscin component, A2E, activates the retinoic acid receptor (RAR). In vitro experiments using luciferase reporter assay, competitional binding assay, analysis of target genes, and chromatin immunoprecipitation (ChIP) assay strongly suggest that A2E is a bona fide ligand for RAR and induces sustained activation of RAR target genes. A2E-induced vascular endothelial growth factor (VEGF) expression in a human retinal pigment epithelial cell line (ARPE-19) and RAR antagonist blocked the up-regulation of VEGF. The conditioned medium of A2E-treated ARPE-19 cells induced tube formation in human umbilical vascular endothelial cells, which was blocked by the RAR antagonist and anti-VEGF antibody. These results suggest that A2E accumulation results in the phenotypic alteration of retinal pigment epithelial cells, predisposing the environment to choroidal neovascularization development. This is mediated through the agonistic function of A2E, at least in part. The results of this study provide a novel potential therapeutic target for this incurable condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RPE lipofuscin and its role in retinal pathobiology
Sparrow, J. R., & Boulton, M. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2005.01.007 · Cited by 644
Parish, C. A., Hashimoto, M., Nakanishi, K., Dillon, J., & Sparrow, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14609 · Cited by 474
Zhou, J., Jang, Y. P., Kim, S. R., & Sparrow, J. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604255103 · Cited by 358
Finnemann, S. C., Leung, L. W., & Rodriguez-Boulan, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052025899 · Cited by 283
The potential role of amyloid in the pathogenesis of age-related macular degeneration
Yoshida, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24635 · Cited by 202
Zhou, J., Cai, B., Jang, Y. P., Pachydaki, S., Schmidt, A. M., & Sparrow, J. R. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.11.009 · Cited by 113
Research works printed but not linked: 27
- Eldred, 1982, Science, 216, 757, 10.1126/science.7079738 · DOI · Paper page
- Ferris, 1984, Arch. Ophthalmol., 102, 1640, 10.1001/archopht.1984.01040031330019 · DOI · Paper page
- Fine, 2000, N. Engl. J. Med., 342, 483, 10.1056/NEJM200002173420707 · DOI · Paper page
- Wormald, 2000, Cochrane Database Syst. Rev., 2, CD002030
- Eldred, 1993, Nature, 361, 724, 10.1038/361724a0 · DOI · Paper page
- Suter, 2000, J. Biol. Chem., 275, 39625, 10.1074/jbc.M007049200 · DOI · Paper page
- Bergmann, 2004, FASEB J., 18, 562, 10.1096/fj.03-0289fje · DOI · Paper page
- Sparrow, 2000, Investig. Ophthalmol. Vis. Sci., 41, 1981
- Sparrow, 2003, J. Biol. Chem., 278, 18207, 10.1074/jbc.M300457200 · DOI · Paper page
- Akiyama, 2002, Investig. Ophthalmol. Vis. Sci., 43, 1367
- Yanagi, 1999, J. Biol. Chem., 274, 12971, 10.1074/jbc.274.19.12971 · doi:10.1074/jbc.274.19.12971
- Kutty, 2001, J. Biol. Chem., 276, 2831, 10.1074/jbc.M007421200 · DOI
- Samuel, 2001, J. Biol. Chem., 276, 28744, 10.1074/jbc.M103587200 · DOI
- Perissi, 2004, Cell, 116, 511, 10.1016/S0092-8674(04)00133-3 · DOI · Paper page
- Korzus, 1998, Science, 279, 703, 10.1126/science.279.5351.703 · DOI · Paper page
- Francis, 2003, Annu. Rev. Physiol., 65, 261, 10.1146/annurev.physiol.65.092101.142528 · DOI · Paper page
- Majewski, 1993, Cancer Lett., 75, 35, 10.1016/0304-3835(93)90204-M · doi:10.1016/0304-3835(93)90204-m
- Pepper, 1994, J. Cell. Biochem., 55, 419, 10.1002/jcb.240550403 · DOI
- Gaetano, 2001, Circ. Res., 88, E38, 10.1161/01.RES.88.4.e38 · DOI
- Saito, 2007, Endocrinology, 148, 1412, 10.1210/en.2006-0900 · DOI · Paper page
- Kodera, 2000, J. Biol. Chem., 275, 33201, 10.1074/jbc.C000517200 · DOI · Paper page
- Moshfeghi, 2006, Ophthalmology, 113, 2002, 10.1016/j.ophtha.2006.05.070 · DOI · Paper page
- Schwesinger, 2001, Am. J. Pathol., 158, 1161, 10.1016/S0002-9440(10)64063-1 · DOI · Paper page
- Cideciyan, 2004, Hum. Mol. Genet., 13, 525, 10.1093/hmg/ddh048 · DOI · Paper page
- Lee, 2007, Cell, 130, 691, 10.1016/j.cell.2007.06.054 · DOI · Paper page
- Gillies, 2007, N. Engl. J. Med., 356, 748
- Dafer, 2007, Semin. Ophthalmol., 22, 201, 10.1080/08820530701543024 · DOI · Paper page
Cited by
Jung, T., Catalgol, B., & Grune, T. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.001 · Cited by 389
Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids
Álvarez, R., Vaz, B., Gronemeyer, H., & de Lera, Á. R. (2014) · Chemical Reviews · doi:10.1021/cr400126u · Cited by 260
Ma, L., Kaufman, Y., Zhang, J., & Washington, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.178657 · Cited by 83
Dwyer, M. A., Kazmin, D., Hu, P., McDonnell, D. P., & Malek, G. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0392 · Cited by 61
Suzumura, A., Terao, R., & Kaneko, H. (2020) · Antioxidants · doi:10.3390/antiox9100920 · Cited by 44
Metadata
- Authors
- Iriyama, A., Fujiki, R., Inoue, Y., Takahashi, H., Tamaki, Y., Takezawa, S., Takeyama, K., Jang, W.-D., Kato, S., & Yanagi, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 283
- Issue
- 18
- Pages
- 11947-11953
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2028358947
- Cited by
- 56
- References
- 6
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4519 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.